Apple Tree says its biotechs face ‘imminent collapse’; Advocates urge J&J to proceed with eye gene therapy; AbbVie buys in vivo CAR-T maker Capstan; and more
Title: Investor Warning of Biotech Collapse and Other Key Industry Developments Publication Date: July 5, 2025 As reported on July 5, 2025, in a condensed version of Endpoints Weekly, key investor and venture-capital firm Apple Tree Partners has voiced concerns…
